ReviewNature reviews. Urology2009
Integrative medicine: complementary therapies and supplements.
Review in Nature reviews. Urology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multifaceted aspects of charge transfer.Physical chemistry chemical physics : PCCP · 2020Article
- Supportive Care Organization in France: a national in-depth survey among patients and oncologists.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017Article
- Young women's experiences with complementary therapies during cancer described through illness blogs.Western journal of nursing research · 2013Article
- The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.The oncologist · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many patients with cancer or other urologic disorders use complementary therapies in an effort to control symptoms and to prevent and treat disease. Complementary modalities are adjuncts to mainstream treatment. These safe, evidence-based therapies reduce symptoms associated with treatment of urologic cancers and other illnesses. They are to be distinguished from 'alternative therapies', which are unproven, potentially harmful, and often promoted as substitutes for mainstream medical care. Accumulating evidence supports the beneficial impact of complementary therapies, such as acupuncture, yoga, meditation and physical activity, on physical and emotional symptoms associated with cancer treatment, for which there are few effective standard interventions. Herbs and other dietary supplements are unlikely to be beneficial, and might be problematic or dangerous when taken during cancer treatment.
Indexed as
Identifiers
19352398What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.